• Antabio, of Lebege, France, said it received a €4.7 million (US$6.4 million) Wellcome Trust Seeding Drug Discovery Award to develop small-molecule drugs for the treatment of life-threatening infections caused by multidrug-resistant Gram-negative bacteria.